FDA notifications. Updates made to Reyataz package insert.
D000069446:Atazanavir Sulfate; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D009842:Oligopeptides / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate